A cooperative study was undertaken to compare the frequency of hepatitis viral antigens and antibodies among blood donors in the Soviet Union and the United States. Age‐ and sex‐stratified blood donors were identified and their sera tested for hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti‐HBs), antibody to the hepatitis B core antigen (anti‐HBc), and antibody to the hepatitis A virus (anti‐HAV). A total of 994 Soviet blood donor sera from five different regions and 1,178 American donor sera from six different regions were tested in the USA. Among the Soviet donors, 450 (45%) had some marker of exposure to the hepatitis B virus; while among the American donors, 94 (8%) did. Of the Soviet donors 848 (85%) were positive for anti‐HAV, compared with 403 (34%) of the American donors. For 1,977 serum samples that were evaluated in both countries for HBsAg, techniques in the USSR identified 36 HBsAg‐positive samples, while the technique in the USA found 38 HBsAg‐positive samples; however, only 24 were judged to be HBsAg‐positive by assays in both countries. Testing of these same 1,977 sera for anti‐HBs revealed that the radioimmunoassay used in the USA identified many more antibody‐positive donors than the immuno‐autoradiography technique used in the Soviet Union. When a portion of the sera were tested by similar radioimmunoassay techniques in each country, there was comparability of results for anti‐HBs, as well as for anti‐HAV, and anti‐HBc. The results permit calculation of age and sex prevalence of hepatitis B and hepatitis A serologic markers for blood donors within and between each country. They also allow comparison, on the same sera, of test methodologies in use in the Soviet Union and in the United States.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.